Journal of Diabetes Investigation (Jul 2023)

Newly discovered knowledge pertaining to glucagon and its clinical applications

  • Dan Kawamori,
  • Shugo Sasaki

DOI
https://doi.org/10.1111/jdi.14009
Journal volume & issue
Vol. 14, no. 7
pp. 829 – 837

Abstract

Read online

Abstract Glucagon has been defined as an ‘insulin counteracting hormone’, which raises blood glucose levels. Recent progress in basic research has shown that glucagon is closely involved in glucose and amino acid metabolism. Additionally, its secretion is intricately, but precisely, regulated by various mechanisms involving molecules in addition to glucose, thus showing its critical role in systemic nutrient metabolism. An innovative dual‐antibody‐linked immunosorbent assay for glucagon that improves measurement accuracy has been developed, and substantial clinical findings have been obtained using this new system. This discovery expanded the pathophysiological significance of glucagon and accelerated the development of its clinical applications in diabetes.

Keywords